{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T10:21:06Z","timestamp":1784802066708,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi Aventis","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"crossref"}]},{"name":"BMS"},{"name":"Eli Lilly"},{"name":"Essex Pharma"},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Janssen\/Johnson and Johnson"},{"DOI":"10.13039\/501100013327","name":"Lundbeck","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.biopsych.2010.01.012","type":"journal-article","created":{"date-parts":[[2010,3,16]],"date-time":"2010-03-16T04:33:25Z","timestamp":1268714005000},"page":"86-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Elaboration on the Early-Onset Hypothesis of Antipsychotic Drug Action: Treatment Response Trajectories"],"prefix":"10.1016","volume":"68","author":[{"given":"Stephen Z.","family":"Levine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2010.01.012_bib1","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archpsyc.60.12.1228","article-title":"Delayed-onset hypothesis of antipsychotic action: A hypothesis tested and rejected","volume":"60","author":"Agid","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.012_bib2","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia","volume":"161","author":"Lehman","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.012_bib3","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.biopsych.2005.02.023","article-title":"Early-onset hypothesis of antipsychotic drug action: A hypothesis tested, confirmed and extended","volume":"57","author":"Leucht","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.012_bib4","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1176\/ajp.2006.163.4.743","article-title":"Time course for antipsychotic treatment response in first-episode schizophrenia","volume":"163","author":"Emsley","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.012_bib5","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1176\/appi.ajp.160.11.2063","article-title":"Early prediction of antipsychotic response in schizophrenia","volume":"160","author":"Correll","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.012_bib6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/npp.2009.164","article-title":"Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia","volume":"35","author":"Kinon","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2010.01.012_bib7","article-title":"Trajectories and antecedents of treatment response over time in early-episode psychosis","author":"Levine","year":"2009","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2010.01.012_bib8","article-title":"Trajectories of antipsychotic response: Moving beyond the responder\/non-responder dichotomy","volume":"35","author":"Kapur","year":"2009","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2010.01.012_bib9","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/archpsyc.62.12.1305","article-title":"Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: A meta-analysis","volume":"62","author":"Kemmler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.012_bib10","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0893-133X(02)00375-5","article-title":"Amisulpride vs. risperidone in chronic schizophrenia: Results of a 6-month double-blind study","volume":"27","author":"Sechter","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2010.01.012_bib11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-1781(99)00075-X","article-title":"Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia","volume":"88","author":"Peuskens","year":"1999","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2010.01.012_bib12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archpsyc.60.6.553","article-title":"A meta-analysis of the efficacy of second-generation antipsychotics","volume":"60","author":"Davis","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.012_bib13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/schbul\/sbn005","article-title":"Dropout rates in randomized clinical trials of antipsychotics: A meta-analysis comparing first- and second-generation drugs and an examination of the role of trial design features","volume":"35","author":"Rabinowitz","year":"2009","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2010.01.012_bib14","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biopsych.2010.01.012_bib15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s002130100711","article-title":"Dropout rates in randomised antipsychotic drug trials","volume":"155","author":"Wahlbeck","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2010.01.012_bib16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/15622970510030090","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia","volume":"6","author":"Falkai","year":"2005","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.012_bib17","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol Rep"},{"key":"10.1016\/j.biopsych.2010.01.012_bib18","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.npp.1301147","article-title":"Linking the PANSS, BPRS, and CGI: Clinical implications","volume":"31","author":"Leucht","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2010.01.012_bib19","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of brief psychiatric rating scale scores","volume":"187","author":"Leucht","year":"2005","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.012_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0447.2008.01308.x","article-title":"Definitions of response and remission in schizophrenia: Recommendations for their use and their presentation","author":"Leucht","year":"2009","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.biopsych.2010.01.012_bib21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: Proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.012_bib22","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/archpsyc.64.4.476","article-title":"Prediction of differential adult health burden by conduct problem subtypes in males","volume":"64","author":"Odgers","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.012_bib23","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/archpsyc.64.5.592","article-title":"Developmental trajectories of male physical violence and theft: Relations to neurocognitive performance","volume":"64","author":"Barker","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.012_bib24","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/archpsyc.63.5.540","article-title":"Longitudinal mapping of cortical thickness and clinical outcome in children and adolescents with attention-deficit\/hyperactivity disorder","volume":"63","author":"Shaw","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.012_bib25","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1001\/archpsyc.63.5.562","article-title":"Prediction of early-onset deviant peer group affiliation: A 12-year longitudinal study","volume":"63","author":"Lacourse","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.012_bib26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/archpsyc.58.4.389","article-title":"Parental and early childhood predictors of persistent physical aggression in boys from kindergarten to high school","volume":"58","author":"Nagin","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.012_bib27","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s11336-004-1261-y","article-title":"Causal inferences with group based trajectory models","volume":"70","author":"Haviland","year":"2005","journal-title":"Psychometrika"},{"key":"10.1016\/j.biopsych.2010.01.012_bib28","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1037\/0021-843X.110.4.600","article-title":"Adolescence-limited versus persistent delinquency: Extending Moffitt's hypothesis into adulthood","volume":"110","author":"White","year":"2001","journal-title":"J Abnorm Psychol"},{"key":"10.1016\/j.biopsych.2010.01.012_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2307\/271063","article-title":"Bayesian model selection in social research","volume":"25","author":"Raftery","year":"1995","journal-title":"Sociol Methodol"},{"key":"10.1016\/j.biopsych.2010.01.012_bib30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/schbul\/16.2.293","article-title":"Gender and the course of schizophrenia: Differences in treated outcomes","volume":"16","author":"Angermeyer","year":"1990","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2010.01.012_bib31","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1176\/appi.ajp.162.10.1785","article-title":"Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: A critical review and meta-analysis","volume":"162","author":"Perkins","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.012_bib32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0920-9964(02)00322-5","article-title":"Are patients enrolled in first episode psychosis drug trials representative of those treated in routine clinical practice?","volume":"61","author":"Rabinowitz","year":"2003","journal-title":"Schizophr Res"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322310000545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322310000545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T14:54:42Z","timestamp":1757775282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322310000545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0006322310000545"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2010.01.012","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elaboration on the Early-Onset Hypothesis of Antipsychotic Drug Action: Treatment Response Trajectories","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2010.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}